Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

covid 19 cough

Respiratory impairment persists for weeks post-discharge in hospitalised COVID-19 patients

Many patients who contract COVID-19 have detectable lung dysfunction 12 weeks after hospital discharge, results have suggested.

Atopic dermatitis on hands

Addition of baricitinib to mainstay of treatment improves signs and symptoms of atopic dermatitis, study findsSubscription

Adding the oral selective Janus kinase 1 and 2 inhibitor, baricitinib, to topical corticosteroid treatment significantly improves the signs and symptoms of moderate-to-severe atopic dermatitis, a phase III study in JAMA Dermatology has suggested.

Montelukast asthma drug

Personalised medicine approach could benefit people with asthmaSubscription

Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.


Gaps between clinical guidelines and practice for lipid management in Europe, researchers findSubscription

Less than 60% of patients receiving lipid-lowering therapy achieve the low-density lipoprotein cholesterol levels set out in European guidelines.


Honey effective at relieving URTI symptoms, analysis concludesSubscription

Honey is superior to usual care for improving symptoms of upper respiratory tract infection symptoms, researchers have concluded.

Woman using an asthma inhaler

Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research findsSubscription

A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.

Oral therapy abrocitinib effective in moderate to severe atopic dermatitis

Oral therapy abrocitinib is effective in moderate-to-severe atopic dermatitisSubscription

Abrocitinib, an oral Janus kinase 1 selective inhibitor, is effective and well-tolerated in patients with moderate-to-severe atopic dermatitis, a study in JAMA Dermatology has suggested.

Prescribing ward round, with pharmacist involvement, cuts errors on paediatric ICU

Prescribing ward round with pharmacist involvement cuts errors on paediatric ICUSubscription

A daily prescribing round in a paediatric intensive care unit led to a reduction in prescribing errors and overall time spent on medicines queries and prescribing.

More research briefings

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs